Booster shots proven strategy to get antibodies up: Serum's Adar Poonawalla

Says policy makers must decide risk-reward of giving a booster dose; Serum Institute has reached trial phase of vaccine for kids above 3, jab should be ready to launch in six months

A new vaccine that would be more effective against Omicron is in the works but there is no reason to believe that having a Covid-19, coronavirus, Covid-19 pandemic,  Covid-19 vaccine will not give adequate protection against variant, Adar Poonawala, CEO, Serum Institute of India said on Tuesday.

Speaking at the confederation of Indian industry (CII) partnership summit, Poonawalla said that policy makers have to decide the risk-reward of giving a booster dose. “We are waiting for the government's decision. We will have the